Infanrix-IPV+Hib

Infanrix-IPV+Hib Caution For Usage

Manufacturer:

GlaxoSmithKline Indonesia
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Caution For Usage
Instructions for Use/Handling: The Hib powder, the Infanrix-IPV suspension and the reconstituted vaccine should be inspected visually for any foreign particulate matter and/or variation of physical aspect prior to administration. In the event of either being observed, discard the vaccine.
Since a white sediment may form during storage, the Infanrix-IPV suspension should be shaken before reconstitution.
The vaccine must be reconstituted by adding the entire contents of the supplied container of the Infanrix-IPV component to the vial containing the Hib powder. Only the components of the vaccine should be mixed together and not with other vaccines or other batches of components. After the addition of the Infanrix-IPV suspension to the Hib powder, the mixture should be well shaken.
The reconstituted Infanrix-IPV+Hib vaccine presents as a slightly more cloudy suspension than the liquid Infanrix-IPV component alone. This is normal and does not impair the performance of the vaccine. In the event of other variations being observed, discard the vaccines.
Remove and discard the first needle and replace it with the second needle. Administer the vaccine.
After reconstitution, the vaccine should be injected immediately.
Withdraw the entire contents of the vial.
Any unused product or waste material should be disposed of in accordance with local requirements.
Incompatibilities: Reconstituted Infanrix-IPV+Hib should not be mixed with other vaccines in the same syringe.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in